Quiet on the insider front: nobody at Lifecore Biomedical, Inc. \DE\ bought or sold LFCR shares in open-market trades this past year.
No open-market insider buying or selling in the last full quarter. Insiders bought in 1 of the last 7 full quarters. Big money check: 99 institutions held LFCR as of Q2 2026, and more funds bought than sold.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| May 28, 2025 | English Aron R. | 10% Owner | Sell | 96,137 | $6.75 | $649K | SEC |
| May 28, 2025 | English Aron R. | 10% Owner | Sell | 1,139,504 | $6.50 | $7.4M | SEC |
| May 28, 2025 | English Aron R. | 10% Owner | Sell | 150,419 | $7.12 | $1.1M | SEC |
| May 16, 2025 | 22NW Fund GP, LLC | 10% Owner | Sell | 12,334 | $7.00 | $86K | SEC |
| May 12, 2025 | 22NW Fund GP, LLC | 10% Owner | Sell | 45,698 | $7.03 | $321K | SEC |
| May 12, 2025 | 22NW Fund GP, LLC | 10% Owner | Sell | 5,098 | $7.00 | $36K | SEC |
| May 12, 2025 | 22NW Fund GP, LLC | 10% Owner | Sell | 700 | $7.00 | $5K | SEC |
| May 7, 2025 | 22NW GP, Inc. | 10% Owner | Sell | 24,543 | $7.08 | $174K | SEC |
| May 7, 2025 | 22NW GP, Inc. | 10% Owner | Sell | 15,847 | $7.01 | $111K | SEC |
| May 7, 2025 | 22NW GP, Inc. | 10% Owner | Sell | 701 | $7.05 | $5K | SEC |
| Jan 8, 2025 | Josephs Paul | CEO | Buy | 17,000 | $5.74 | $98K | SEC |
| Oct 7, 2024 | Wynnefield Capital, Inc. Profit Sharing Plan | 10% Owner | Buy | 169,753 | $4.10 | $696K | SEC |
| Oct 7, 2024 | Wynnefield Capital, Inc. Profit Sharing Plan | 10% Owner | Buy | 122,930 | $4.10 | $504K | SEC |
| Oct 7, 2024 | Legion Partners Asset Management, LLC | Director | Buy | 152,102 | $4.10 | $624K | SEC |
| Oct 7, 2024 | Legion Partners Asset Management, LLC | Director | Buy | 1,311,312 | $4.10 | $5.4M | SEC |
There were no open-market insider trades in LFCR in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
99 investment managers reported holding LFCR in SEC Form 13F filings for Q2 2026.
No congressional trades in LFCR were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).